全文获取类型
收费全文 | 2385431篇 |
免费 | 178605篇 |
国内免费 | 6298篇 |
专业分类
耳鼻咽喉 | 32374篇 |
儿科学 | 76477篇 |
妇产科学 | 63257篇 |
基础医学 | 353030篇 |
口腔科学 | 64293篇 |
临床医学 | 216620篇 |
内科学 | 463033篇 |
皮肤病学 | 52123篇 |
神经病学 | 187640篇 |
特种医学 | 89287篇 |
外国民族医学 | 506篇 |
外科学 | 358229篇 |
综合类 | 54151篇 |
现状与发展 | 17篇 |
一般理论 | 852篇 |
预防医学 | 184910篇 |
眼科学 | 55419篇 |
药学 | 179203篇 |
41篇 | |
中国医学 | 6421篇 |
肿瘤学 | 132451篇 |
出版年
2021年 | 21023篇 |
2019年 | 21002篇 |
2018年 | 28556篇 |
2017年 | 21659篇 |
2016年 | 23966篇 |
2015年 | 27442篇 |
2014年 | 38354篇 |
2013年 | 55981篇 |
2012年 | 77688篇 |
2011年 | 82653篇 |
2010年 | 48997篇 |
2009年 | 46142篇 |
2008年 | 76775篇 |
2007年 | 81669篇 |
2006年 | 82380篇 |
2005年 | 79885篇 |
2004年 | 75742篇 |
2003年 | 73059篇 |
2002年 | 70509篇 |
2001年 | 109672篇 |
2000年 | 112439篇 |
1999年 | 94608篇 |
1998年 | 27611篇 |
1997年 | 24346篇 |
1996年 | 24549篇 |
1995年 | 23169篇 |
1994年 | 21290篇 |
1993年 | 19994篇 |
1992年 | 72324篇 |
1991年 | 70348篇 |
1990年 | 68638篇 |
1989年 | 65872篇 |
1988年 | 60503篇 |
1987年 | 59293篇 |
1986年 | 55366篇 |
1985年 | 53119篇 |
1984年 | 39375篇 |
1983年 | 33462篇 |
1982年 | 19895篇 |
1979年 | 35903篇 |
1978年 | 25668篇 |
1977年 | 21246篇 |
1976年 | 20341篇 |
1975年 | 21821篇 |
1974年 | 26164篇 |
1973年 | 24814篇 |
1972年 | 23204篇 |
1971年 | 22039篇 |
1970年 | 20248篇 |
1969年 | 19319篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
311.
Jennifer C. Sasaki Ashley Allemang Steven M. Bryce Laura Custer Kerry L. Dearfield Yasmin Dietz Azeddine Elhajouji Patricia A. Escobar Albert J. Fornace Jr Roland Froetschl Sheila Galloway Ulrike Hemmann Giel Hendriks Heng-Hong Li Mirjam Luijten Gladys Ouedraogo Lauren Peel Stefan Pfuhler Daniel J. Roberts Véronique Thybaud Jan van Benthem Carole L. Yauk Maik Schuler 《Environmental and molecular mutagenesis》2020,61(1):114-134
In May 2017, the Health and Environmental Sciences Institute's Genetic Toxicology Technical Committee hosted a workshop to discuss whether mode of action (MOA) investigation is enhanced through the application of the adverse outcome pathway (AOP) framework. As AOPs are a relatively new approach in genetic toxicology, this report describes how AOPs could be harnessed to advance MOA analysis of genotoxicity pathways using five example case studies. Each of these genetic toxicology AOPs proposed for further development includes the relevant molecular initiating events, key events, and adverse outcomes (AOs), identification and/or further development of the appropriate assays to link an agent to these events, and discussion regarding the biological plausibility of the proposed AOP. A key difference between these proposed genetic toxicology AOPs versus traditional AOPs is that the AO is a genetic toxicology endpoint of potential significance in risk characterization, in contrast to an adverse state of an organism or a population. The first two detailed case studies describe provisional AOPs for aurora kinase inhibition and tubulin binding, leading to the common AO of aneuploidy. The remaining three case studies highlight provisional AOPs that lead to chromosome breakage or mutation via indirect DNA interaction (inhibition of topoisomerase II, production of cellular reactive oxygen species, and inhibition of DNA synthesis). These case studies serve as starting points for genotoxicity AOPs that could ultimately be published and utilized by the broader toxicology community and illustrate the practical considerations and evidence required to formalize such AOPs so that they may be applied to genetic toxicity evaluation schemes. Environ. Mol. Mutagen. 61:114–134, 2020. © 2019 Wiley Periodicals, Inc. 相似文献
312.
313.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.314.
315.
316.
317.
318.
To determine the protective effect of aloe-emodin (AE) from high glucose induced toxicity in RIN-5F (pancreatic β-cell) cell and restoration of its function was analyzed. RIN-5F cells have been cultured in high glucose (25 mM glucose) condition, with and without AE treatment. RIN-5F cells cultured in high glucose decreased cell viability and increased ROS levels after 48 hr compared with standard medium (5.5 mM glucose). Glucotoxicity was confirmed by significantly increased ROS production, increased pro-inflammatory (IFN-γ, IL-1β,) & decreased anti-inflammatory (IL-6&IL-10) cytokine levels, increased DNA fragmentation. In addition, we found increased Bax, caspase 3, Fadd, and Fas and significantly reduced Bcl-2 expression after 48 hr. RIN-5F treated with both high glucose and AE (20 μM) decreased ROS generation and prevent RIN-5F cell from glucotoxicity. In addition, AE treated cells cultured in high glucose were transferred to standard medium, normal responsiveness to glucose was restored within 8hr and normal basal insulin release within 24 hr was achieved when compared to high glucose. 相似文献
319.
320.